Blue Sail Medical Co.,Ltd. opened its Blue Sail Shanghai Innovation Center (BSIC) in July 2020 at ATLATL Innovation Center, which built the customized GMP facility after a 10-month effort. Blue Sail entered the cardiovascular arena after acquisition of Biosensors International Group Ltd. (abbr. Biosensors), who has been developing and distributing critical care catheter systems and related devices used during heart surgery and intensive care. They have been working on drug-eluting stents, drug-coated stents, and bare metal stents, as well as angioplasty catheters for the treatment of coronary artery disease, offering interventional devices and solutions for patients living with coronary artery disease. In the near future, Bluesail will have four product lines in the innovation center: Coronary intervention products, Structural heart products, Peripheral vascular products, and Neurovascular products. With the concept of mutual building and sharing, Blue Sail built the platform for both health protection and health care via industry investment and venture capital. Blue Sail is committed to developing a world-class leading enterprise in the comprehensive medical industry as a famous brand trusted by the public.